The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Radie Robert S since 2014.
The trader's CIK number is 1591113.
At the time of the last reporting, Radie Robert S was the President and CEO of Zyla Life Sciences. (stock ticker symbol ZCOR).
Also see all insider trading activities at Zyla Life Sciences.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | PRTK | 0 | $0 | 3,750 | $26,775 | 0 | $0 |
| 2018 | PRTK | 0 | $0 | 3,000 | $42,660 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ZCOR | 0 | $0 | 0 | $0 | 132,000 | $330,000 |
| 2016 | ZCOR | 0 | $0 | 60,000 | $440,934 | 0 | $0 |
| 2015 | ZCOR | 0 | $0 | 52,260 | $550,726 | 0 | $0 |
| 2014 | ZCOR | 0 | $0 | 89,040 | $862,023 | 0 | $0 |
1. Paratek Pharmaceuticals, Inc. (PRTK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-15 | PRTK | Sale | 3,750 | 7.14 | 26,775 |
| 2018-02-05 | PRTK | Sale | 3,000 | 14.22 | 42,660 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-31 | ZCOR | Option Ex | 132,000 | 2.50 | 330,000 |
| 2016-10-03 | EGLT | Sale | 15,000 | 7.47 | 112,050 |
| 2016-07-05 | EGLT | Sale | 5,000 | 4.94 | 24,700 |
| 2016-07-06 | EGLT | Sale | 5,000 | 5.02 | 25,099 |
| 2016-07-01 | EGLT | Sale | 5,000 | 5.07 | 25,350 |
| 2016-04-05 | EGLT | Sale | 5,000 | 6.99 | 34,950 |
| 2016-04-01 | EGLT | Sale | 5,000 | 6.94 | 34,700 |
| 2016-04-04 | EGLT | Sale | 5,000 | 6.99 | 34,950 |
| 2016-01-11 | EGLT | Sale | 3,000 | 9.65 | 28,950 |
| 2016-01-07 | EGLT | Sale | 3,000 | 9.61 | 28,830 |
| 2016-01-08 | EGLT | Sale | 4,000 | 9.69 | 38,760 |
| 2016-01-04 | EGLT | Sale | 1,500 | 10.47 | 15,705 |
| 2016-01-05 | EGLT | Sale | 1,400 | 11.11 | 15,554 |
| 2016-01-06 | EGLT | Sale | 2,100 | 10.16 | 21,336 |
| 2015-10-01 | EGLT | Sale | 15,000 | 12.27 | 184,050 |
| 2015-07-07 | EGLT | Sale | 3,000 | 12.31 | 36,930 |
| 2015-07-08 | EGLT | Sale | 3,000 | 11.62 | 34,860 |
| 2015-07-06 | EGLT | Sale | 3,000 | 11.94 | 35,820 |
| 2015-07-02 | EGLT | Sale | 3,000 | 12.44 | 37,320 |
| 2015-07-01 | EGLT | Sale | 3,000 | 13.22 | 39,660 |
| 2015-04-01 | EGLT | Sale | 11,130 | 11.25 | 125,212 |
| 2015-01-02 | EGLT | Sale | 11,130 | 5.11 | 56,874 |
| 2014-09-09 | EGLT | Sale | 20,020 | 9.54 | 190,990 |
| 2014-09-10 | EGLT | Sale | 20,020 | 9.68 | 193,793 |
| 2014-09-05 | EGLT | Sale | 30,000 | 9.79 | 293,700 |
| 2014-09-08 | EGLT | Sale | 19,000 | 9.66 | 183,540 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Radie Robert S (President and CEO of Zyla Life Sciences at the time of this reporting) see the Securities and Exchange Commission (SEC) website.